Johnson Pharmacare Limited (BOM:532154)

Johnson Pharmacare Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	-557.34	-5.84	-1.96	-12.91	0.97
Other Operating Activities	142.7	-	-	-0	-0
Change in Accounts Receivable	-22.26	-	-	10.5	6.3
Change in Accounts Payable	-9.57	-	-	-	-6.5
Change in Other Net Operating Assets	13.5	-13.25	1.51	-1.59	48.2
Operating Cash Flow	-575.67	-19.09	-0.45	-4.01	48.97
Sale of Property, Plant & Equipment	225.67	-	-	-	-
Investment in Securities	-	32.67	-	86.21	-
Investing Cash Flow	368.37	32.67	-	-9.38	-
Short-Term Debt Issued	-	-	0.45	13	-
Long-Term Debt Issued	207.97	-	-	-	-
Total Debt Issued	207.97	-	0.45	13	-
Short-Term Debt Repaid	-	-13.45	-	-	-0.83
Total Debt Repaid	-	-13.45	-	-	-0.83
Net Debt Issued (Repaid)	207.97	-13.45	0.45	13	-0.83
Financing Cash Flow	207.97	-13.45	0.45	13	-0.83
Miscellaneous Cash Flow Adjustments	-	-	-	-	-50.06
Net Cash Flow	0.66	0.13	-0	-0.39	-1.92
Cash Income Tax Paid	-	-	-	-0.38	0.38
Levered Free Cash Flow	-255.22	-18.98	0.28	10.37	48.91
Unlevered Free Cash Flow	-253.58	-18.98	0.28	10.37	48.91
Change in Working Capital	-18.34	-13.25	1.51	8.91	48

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 13, 2026

Data Sources Report a data error